Briefs: Sun Pharma and Venus Remedies
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
Subscribe To Our Newsletter & Stay Updated